即时检测结核病的方法：纳米技术/微流控技术的应用。
Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.
机构信息
Demirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
出版信息
Biotechnol Adv. 2013 Jul-Aug;31(4):438-49. doi: 10.1016/j.biotechadv.2013.01.006. Epub 2013 Jan 26.
Abstract
Tuberculosis (TB) remains one of the most devastating infectious diseases and its eradication is still unattainable given the limitations of current technologies for diagnosis, treatment and prevention. The World Health Organization's goal to eliminate TB globally by 2050 remains an ongoing challenge as delayed diagnosis and misdiagnosis of TB continue to fuel the worldwide epidemic. Despite considerable improvements in diagnostics for the last few decades, a simple and effective point-of-care TB diagnostic test is yet not available. Here, we review the current assays used for TB diagnosis, and highlight the recent advances in nanotechnology and microfluidics that potentially enable new approaches for TB diagnosis in resource-constrained settings.
摘要
结核病（TB）仍然是最具破坏性的传染病之一，由于当前诊断、治疗和预防技术的局限性，其消除仍然遥不可及。世界卫生组织到 2050 年在全球消除结核病的目标仍然是一个持续存在的挑战，因为结核病的诊断延迟和误诊仍在助长全球疫情。尽管在过去几十年中诊断技术有了相当大的改进，但仍然没有简单有效的即时护理结核病诊断测试。在这里，我们回顾了目前用于结核病诊断的检测方法，并强调了纳米技术和微流控技术的最新进展，这些技术可能为资源有限的环境中的结核病诊断提供新方法。
相似文献
1
Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.即时检测结核病的方法：纳米技术/微流控技术的应用。
Biotechnol Adv. 2013 Jul-Aug;31(4):438-49. doi: 10.1016/j.biotechadv.2013.01.006. Epub 2013 Jan 26.
2
Recent tuberculosis diagnosis toward the end TB strategy.结核病防治策略后期的近期结核病诊断
J Microbiol Methods. 2016 Apr;123:51-61. doi: 10.1016/j.mimet.2016.02.007. Epub 2016 Feb 5.
3
Opportunities and challenges for the application of microfluidic technologies in point-of-care veterinary diagnostics.微流控技术在即时兽医诊断中的应用机遇与挑战
Mol Cell Probes. 2016 Oct;30(5):331-341. doi: 10.1016/j.mcp.2016.07.004. Epub 2016 Jul 16.
5
Point-of-care diagnostic tests for tuberculosis disease.即时检测结核病的诊断测试。
Sci Transl Med. 2022 Apr 6;14(639):eabj4124. doi: 10.1126/scitranslmed.abj4124.
6
Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.在资源匮乏和分散的环境中进行病毒性肝炎即时检测的创新技术。
J Viral Hepat. 2018 Feb;25(2):108-117. doi: 10.1111/jvh.12827. Epub 2017 Dec 27.
7
Point-of-Care Diagnostics in Low Resource Settings: Present Status and Future Role of Microfluidics.即时检测在资源有限环境中的应用：微流控的现状和未来作用。
Biosensors (Basel). 2015 Aug 13;5(3):577-601. doi: 10.3390/bios5030577.
8
Nucleic-acid testing, new platforms and nanotechnology for point-of-decision diagnosis of animal pathogens.用于动物病原体即时诊断的核酸检测、新平台及纳米技术
Methods Mol Biol. 2015;1247:253-83. doi: 10.1007/978-1-4939-2004-4_20.
9
Nanotechnology and tuberculosis: An old disease with new treatment strategies.纳米技术与结核病：古老疾病的新型治疗策略。
Tuberculosis (Edinb). 2022 Jul;135:102208. doi: 10.1016/j.tube.2022.102208. Epub 2022 May 7.
10
Nano/Microfluidics for diagnosis of infectious diseases in developing countries.纳米/微流控技术在发展中国家传染病诊断中的应用。
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):449-57. doi: 10.1016/j.addr.2009.11.016. Epub 2009 Nov 30.
引用本文的文献
1
Smartphone-integrated colorimetric detection of ascorbic acid sensor based on CeCu-MOF nanozymes with enhanced triple-enzyme mimetic activity.基于具有增强三酶模拟活性的CeCu-MOF纳米酶的智能手机集成比色法检测抗坏血酸传感器
Mikrochim Acta. 2025 Aug 11;192(9):580. doi: 10.1007/s00604-025-07428-y.
2
Progress in mechanism-based diagnosis and treatment of tuberculosis comorbid with tumor.结核病合并肿瘤的基于机制的诊断与治疗进展。
Front Immunol. 2024 Jan 17;15:1344821. doi: 10.3389/fimmu.2024.1344821. eCollection 2024.
3
Rapid Diagnosis of Drug-Resistant Tuberculosis-Opportunities and Challenges.耐药结核病的快速诊断——机遇与挑战
Pathogens. 2023 Dec 27;13(1):27. doi: 10.3390/pathogens13010027.
4
Interfacial reactivity-modulated fluorescent metal-organic frameworks for sensitive detection of interferon-γ towards tuberculosis diagnosis.用于结核病诊断的干扰素-γ灵敏检测的界面反应性调制荧光金属有机骨架
Mikrochim Acta. 2023 Dec 5;191(1):6. doi: 10.1007/s00604-023-06088-0.
5
Aptamer-Based Point-of-Care Devices: Emerging Technologies and Integration of Computational Methods.基于适配体的即时检测设备：新兴技术与计算方法的整合。
Biosensors (Basel). 2023 May 22;13(5):569. doi: 10.3390/bios13050569.
6
Evaluation of immunodominant peptides of in vivo expressed mycobacterial antigens in an ELISA-based diagnostic assay for pulmonary tuberculosis.基于 ELISA 的肺结核病诊断检测中体内表达分枝杆菌抗原免疫显性肽的评估。
Braz J Microbiol. 2023 Sep;54(3):1751-1759. doi: 10.1007/s42770-023-00998-0. Epub 2023 May 18.
7
Increasing the initiation of antiretroviral therapy through optimal placement of diagnostic technologies for pediatric HIV in Zimbabwe: A modeling analysis.通过在津巴布韦优化儿科艾滋病诊断技术的定位来增加抗逆转录病毒疗法的启动：建模分析。
Int J Infect Dis. 2023 Sep;134:31-38. doi: 10.1016/j.ijid.2023.05.013. Epub 2023 May 16.
8
DNA Nanostructures in the Fight Against Infectious Diseases.用于对抗传染病的DNA纳米结构。
Adv Nanobiomed Res. 2021 Mar;1(3):2000049. doi: 10.1002/anbr.202000049. Epub 2021 Jan 6.
9
Recent applications and strategies in nanotechnology for lung diseases.纳米技术在肺部疾病中的最新应用与策略
Nano Res. 2021;14(7):2067-2089. doi: 10.1007/s12274-020-3180-3. Epub 2021 Jan 8.
10
Detection of Bacterial and Viral Pathogens Using Photonic Point-of-Care Devices.使用光子即时检测设备检测细菌和病毒病原体。
Diagnostics (Basel). 2020 Oct 19;10(10):841. doi: 10.3390/diagnostics10100841.
本文引用的文献
1
Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe.利用 BlaC 特异性荧光探针快速即时检测结核病原体。
Nat Chem. 2012 Oct;4(10):802-9. doi: 10.1038/nchem.1435. Epub 2012 Sep 2.
2
Portable microfluidic chip for detection of Escherichia coli in produce and blood.用于检测农产品和血液中大肠杆菌的便携式微流控芯片。
Int J Nanomedicine. 2012;7:2591-600. doi: 10.2147/IJN.S29629. Epub 2012 May 29.
3
Efficient on-chip isolation of HIV subtypes.高效的 HIV 亚型芯片隔离。
Lab Chip. 2012 Apr 21;12(8):1508-15. doi: 10.1039/c2lc20706k. Epub 2012 Mar 6.
4
Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.尿液脂阿拉伯甘露聚糖条检测对 HIV 感染住院患者中结核病检测的诊断准确性。
Eur Respir J. 2012 Nov;40(5):1211-20. doi: 10.1183/09031936.00201711. Epub 2012 Feb 23.
5
Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.用于艾滋病毒和结核病的即时诊断：现状、研发进程及未满足的需求
Discov Med. 2012 Jan;13(68):35-45.
6
Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis.γ-干扰素释放试验在 HIV 感染患者中诊断活动性结核病的系统评价和荟萃分析。
PLoS One. 2011;6(11):e26827. doi: 10.1371/journal.pone.0026827. Epub 2011 Nov 1.
7
Immunodiagnosis of tuberculosis: state of the art.结核病的免疫诊断：最新进展。
Med Princ Pract. 2012;21(1):4-13. doi: 10.1159/000331583. Epub 2011 Oct 20.
8
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.一种低成本的尿液抗原即时检测用于艾滋病相关肺结核的诊断准确性：一项描述性研究。
Lancet Infect Dis. 2012 Mar;12(3):201-9. doi: 10.1016/S1473-3099(11)70251-1. Epub 2011 Oct 17.
9
Point-of-care tuberculosis diagnosis: are we there yet?即时检验结核病诊断：我们做到了吗？
Lancet Infect Dis. 2012 Mar;12(3):169-70. doi: 10.1016/S1473-3099(11)70257-2. Epub 2011 Oct 17.
10
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis.干扰素-γ 释放试验在中低收入国家成人活动性肺结核诊断中的应用：系统评价和荟萃分析。
J Infect Dis. 2011 Nov 15;204 Suppl 4(Suppl 4):S1120-9. doi: 10.1093/infdis/jir410.
Zotero 插件